Recommended Stories
Reform of Federal Marijuana Law and Potential Impacts on State Medical Marijuana Programs
Momentum has been gathering behind efforts to reclassify marijuana under the Controlled Substances Act (CSA). Regardless of how marijuana is rescheduled under federal law, the Food and Drug Administration (FDA) could consider medical marijuana products to be unapproved “new drugs” subject to regulation under the Food, Drug, and Cosmetic Act (FDCA).
Scranton Attorney Gets Prison Time After Pleading Guilty to Forgery, Tampering With Records
James Conaboy was sentenced to between 30 days and one year in prison followed by four years on probation. He was disbarred last year for misleading clients about a phantom settlement.
Resolving Litigation: Encouraging the Next Generation to Address Conflict
For this month’s feature, I had the pleasure of speaking with Robyn Weinstein, who has dedicated her career to the advancement and craft of conflict resolution.
Featured Firms
Presented by BigVoodoo
More From ALM
View Now
View Now
View Now
Philadelphia, PA
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Learn More
Dallas, TX
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Learn More
London
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
Learn More
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
Apply Now ›
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
Apply Now ›
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
Apply Now ›
Connecticut Law Tribune
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
View Announcement ›